Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by BurconNutriFanon Sep 21, 2017 2:39pm
49 Views
Post# 26727111

RE:RE:RE:When was the last time anybody read...

RE:RE:RE:When was the last time anybody read...wwwmeinc,

Funny the last time you said you left this investment and would keep an eye on it to your new investment. Here you are a few days again trolling and bashing a company you no longer invest in?
On top of that, you bring Viacycte news that only a person familiar with the company would bring. Since Viacyte is not a publically traded company, how could you own any of it? But you sure have a hard on for it, and a hard on for Shapiro. Trying to suggest Shapiro is no longer working with Sva and that has something to do with no news from Sva. 

wwwmeinc, your posts are obvious. Your subtle hints at pointing out potential negatives repeatedly after you apparently have no interest in the company are clear as mud.  Yoy have pointed out these facts at nauseasom.

You want the IND induactions for the FDA appliocation. You want to know any modifiactions made to the pouch.  You try to link Shapiro and Viacyte progress indirectly to lack of news of Sva.
Do you really think posting on this blog is going to get that information? Or make a differnce to investors decision on Sva?

Answer me this Mr . "Hard on for Shapiro and Viacycte"?  How come Shapiro's patent for his pouch has not been yet approved?   Why is Viacycte using sentinel cells (not in a delivery device) to test safety for its FDA trial? Besides Gore? Where are all the companies that have previously funded Viacycyte now on their investment?  Viacycte is desperate to get something out of this trail or it is game over.

Sernova is the second stage with its revoluntionary Hemophilia break through. Sva has three other diabetic appliactions for its pouch. Also they are working on a Thyroid application as well.

WWW"hard on for Shapiro and Viacycte"MEINC,  you have stated your position repeatedly. We get it., Too bad you're not playing nice with Sonny otherwise he would tell you about the modified pouch design that has the FDA drooling at infinte possibilities.
Bullboard Posts